Winning a losing battle
Brunch|January 27, 2024
Hollywood's favourite weight-loss drug is now available on prescription in many countries. It will flood the Indian market soon. Is it worth it?
VIR SANGHVI
Winning a losing battle

Semaglutide was meant to be a drug for diabetics and is now a global rage. Drugs like Ozempic make people crave food less and have now turned into a drug for weight loss and appetite suppression. ADOBE STOCK

Do you sometimes run into (mostly well-off) people who have suddenly lost a lot of weight? And when you ask them how they managed it, the answer is always vague: "Working out a bit", or "Eating healthy" or something like that? But as most of them do not seem to have changed their lifestyles or habits, you begin to wonder how they did it. The answer, more often than not, is one word: Semaglutide.

If you haven't heard of Semaglutide, which is now a global rage, here is what it is. It's a drug that affects our satiety centres and tells us that we are full even if we have only eaten a little bit.

It is to fatties what Viagra was to impotent men. (There, I've said it.) When the drug was introduced, it was meant for diabetics, because it has shown dramatic results in treating Type II Diabetes. But as time went on, doctors discovered that patients on Semaglutide not only ate less, they also lost interest in food halfway through a meal. I have a slight problem with my sugars, but am fortunate to have a doctor, Ambrish Mithal, who knows what current international research says.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BRUNCHView all
Fit Check? Look Behind You
Brunch

Fit Check? Look Behind You

In gyms, someone is always filming. We are all in the frame without meaning to be. Is privacy at odds with fitness goals? Is consent even possible with all those mirrors?

time-read
2 mins  |
November 23, 2024
Avantika Dassani
Brunch

Avantika Dassani

Actor, @AvantikaDassani

time-read
1 min  |
November 23, 2024
Keep your i on this BMW
Brunch

Keep your i on this BMW

The brand's beloved sedan has now gone electric. The i5 M60 has a sci-fi roar and razor-sharp graphics. It's worth the hype

time-read
2 mins  |
November 23, 2024
Why adapt when you can evolve?
Brunch

Why adapt when you can evolve?

Sometimes, the movie or show does it better than the book it is based on. Here's when to stream not flip

time-read
2 mins  |
November 23, 2024
Sharp edges, blunt words
Brunch

Sharp edges, blunt words

British chef Heston Blumenthal has gone public about his struggle with ADHD and bipolar syndrome. He hopes it calms kitchens down. It's hot in there already

time-read
3 mins  |
November 23, 2024
The suitable boy
Brunch

The suitable boy

He's played lovers, taxi drivers, street rats and rich brats. He's redefining what it means to be the token Brown boy on set. But would he be on a reality show? Ishaan Khatter tells us why he's a career chameleon and how he got here

time-read
4 mins  |
November 23, 2024
Stay stylish in your cubicle
Brunch

Stay stylish in your cubicle

Everyone's back at the office. Covid flexibilities are long forgotten. But being comfortable is still key. So, what are we wearing to work?

time-read
2 mins  |
November 23, 2024
Hey, I found you online
Brunch

Hey, I found you online

Baby pics, emo selfies, old tweets outing the ex. If it makes you cringe, it makes HR departments do too. Here's how to clean up your digital footprint

time-read
3 mins  |
November 23, 2024
Is It Scrolling Or Screening?
Brunch

Is It Scrolling Or Screening?

Being on the phone while the TV plays is the new normal. Just don't do it when there's company. A case for what it means to be present

time-read
2 mins  |
November 16, 2024
This week, we're...
Brunch

This week, we're...

Preferring the spinoff.

time-read
2 mins  |
November 16, 2024